A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627)

Clinical trial NCT01644617 · COMPLETED

Trial details

NCT number: NCT01644617
Sponsor: ALK-Abelló A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rhinitis, Allergic, Perennial Rhinitis, Allergic, Nonseasonal

Start date: 2012-10-01
Primary completion: 2013-08-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.